Human Glucocorticoid Receptor β Binds RU-486 and Is TranscriptionallyActive
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Human glucocorticoid receptor (hGR) is expressed as two alternately spliced C-terminal isoforms, alpha and beta. In contrast to the canonical hGRalpha, hGRbeta is a nucleus-localized orphan receptor thought not to bind ligand and not to affect gene transcription other than by acting as a dominant negative to hGRalpha. Here we used confocal microscopy to examine the cellular localization of transiently expressed fluorescent protein-tagged hGRbeta in COS-1 and U-2 OS cells. Surprisingly, yellow fluorescent protein (YFP)-hGRbeta was predominantly located in the cytoplasm and translocated to the nucleus following application of the glucocorticoid antagonist RU-486. This effect of RU-486 was confirmed with transiently expressed wild-type hGRbeta. Confocal microscopy of coexpressed YFP-hGRbeta and cyan fluorescent protein-hGRalpha in COS-1 cells indicated that the receptors move into the nucleus independently. Using a ligand binding assay, we confirmed that hGRbeta bound RU-486 but not the hGRalpha ligand dexamethasone. Examination of the cellular localization of YFP-hGRbeta in response to a series of 57 related compounds indicated that RU-486 is thus far the only identified ligand that interacts with hGRbeta. The selective interaction of RU-486 with hGRbeta was also supported by molecular modeling and computational docking studies. Interestingly, microarray analysis indicates that hGRbeta, expressed in the absence of hGRalpha, can regulate gene expression and furthermore that occupation of hGRbeta with the antagonist RU-486 diminishes that capacity despite the lack of helix 12 in the ligand binding domain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hGR-β has recently been found to bind the GR antagonist, RU38486, and is transcriptionally active (even in the absence of ligand, similar to GR-α)”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [79]
Experimental — accuracy not yet measuredIn the citing paper
“Although GRβ does not bind glucocorticoids, it actively binds GR antagonist mifepristone (RU486),49”
From Corticosteroids (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
The Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Self-citation
Research works printed but not linked: 2
- 10.1210/endo.140.3.6581 · doi:10.1210/endo.140.3.6581 · Paper page
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Glucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
Self-citationCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationA General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
Glucocorticoid receptor control of transcription: precision and plasticity via allostery
Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.152 · Cited by 533
Glucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Self-citationCytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Critical Illness-Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Chest · doi:10.1378/chest.08-1149 · Cited by 299
Comprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
Tian, R., Hou, G., Li, D., & Yuan, T.-F. (2014) · The Scientific World Journal · doi:10.1155/2014/780616 · Cited by 237
Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling
Revollo, J. R., & Cidlowski, J. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04986.x · Cited by 220
Self-citationPetta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., & Libert, C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-15 · Cited by 203
A Role for Glucocorticoids in Stress-Impaired Reproduction: Beyond the Hypothalamus and Pituitary
Whirledge, S., & Cidlowski, J. A. (2013) · Endocrinology · doi:10.1210/en.2013-1652 · Cited by 203
Progesterone: the ultimate endometrial tumor suppressor
Yang, S., Thiel, K. W., & Leslie, K. K. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.01.005 · Cited by 194
Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
Liberman, A. C., Budziñski, M. L., Sokn, C., Gobbini, R. P., Steininger, A., & Arzt, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00235 · Cited by 181
Molecular mechanisms regulating glucocorticoid sensitivity and resistance
Gross, K. L., Lu, N. Z., & Cidlowski, J. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.001 · Cited by 180
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript demonstrated that GRβ regulates gene expression even in the absence of GRα and interacts with the GRα antagonist/partial agonist RU-486, which diminishes its transcriptional capacity (Lewis-Tuffin et al., 2007).”
BackgroundTissue-specific glucocorticoid action: a family affair
Gross, K. L., & Cidlowski, J. A. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.07.009 · Cited by 180
“GRβ also regulates gene expression independent of GRα, and RU-486 diminishes this capacity [46].”
BackgroundInfluentialKino, T., Su, Y. A., & Chrousos, G. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0098-z · Cited by 179
“The cytoplasmic to nuclear translocation of GRb demonstrated by the previous work was quite slow compared with that of GRa: in the former, the receptor took 6 h to complete its translocation whereas in the latter it did this within minutes [ 11 ].”
InfluentialGlucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity
Kino, T., Manoli, I., Kelkar, S., Wang, Y., Su, Y. A., & Chrousos, G. P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.110 · Cited by 174
“This report also described that GRβ had 10–20 times lower binding affinity to RU 486 than GRα [10].”
InfluentialDiscovery of a Functional Glucocorticoid Receptor β-Isoform in Zebrafish
Schaaf, M. J. M., Champagne, D., van Laanen, I. H. C., van Wijk, D. C. W. A., Meijer, A. H., Meijer, O. C., Spaink, H. P., & Richardson, M. K. (2008) · Endocrinology · doi:10.1210/en.2007-1364 · Cited by 161
Dubois‐Camacho, K., Ottum, P. A., Franco-Muñoz, D., la Fuente, M. D., Torres, A., Díaz-Jiménez, D., Olivares-Morales, M., Astudillo, G. E., Quera, R., & Hermoso, M. A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6628 · Cited by 152
Glucocorticoid-Induced Apoptosis of Healthy and Malignant Lymphocytes
Smith, L. K., & Cidlowski, J. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82001-1 · Cited by 144
“Furthermore, GRβ can selectively bind the GR antagonist RU-486 and this binding diminishes its intrinsic transcriptional activity (Lewis-Tuffin et al., 2007).”
BackgroundMechanisms of Glucocorticoid Action During Development
Busada, J. T., & Cidlowski, J. A. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.004 · Cited by 168
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Discovery of Glucocorticoid Receptor-β in Mice with a Role in Metabolism
Hinds, T. D., Ramakrishnan, S., Cash, H. A., Stechschulte, L. A., Heinrich, G., Najjar, S. M., & Sanchez, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0411 · Cited by 129
Specificity and sensitivity of glucocorticoid signaling in health and disease
Cain, D. W., & Cidlowski, J. A. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.007 · Cited by 127
Biochemical Basis of Asthma Therapy
Barnes, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.206466 · Cited by 136
Giembycz, M. A., Kaur, M., Leigh, R., & Newton, R. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707627 · Cited by 135
“In addition, the model depicted in Figure 3 shows that LABAs enhanced GRE-dependent transcription in the presence of concentrations of glucocorticoids that will promote the translocation of all GR to the nucleus (Chivers et al., 2004; Lewis-Tuffin et al., 2007).”
MethodZhang, X., Clark, A. F., & Yorio, T. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1279 · Cited by 118
Kumamaru, E., Numakawa, T., Adachi, N., Yagasaki, Y., Izumi, A., Niyaz, M., Kudo, M., & Kunugi, H. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0264 · Cited by 116
Mellor, C. L., Steinmetz, F. P., & Cronin, M. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1089471 · Cited by 127
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
“Similarly, GR is expressed as two mRNA splice isoforms that give rise to the variants GRα and GRβ, which show differential ligand-dependent transcriptional profiles (Lewis-Tuffin et al., 2007).”
Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
The zebrafish as a model system for glucocorticoid receptor research
Schaaf, M. J. M., Chatzopoulou, A., & Spaink, H. P. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2008.12.014 · Cited by 117
Li, L.-B., Leung, D. Y. M., Martin, R. J., & Goleva, E. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0015oc · Cited by 99
Steroid resistance in asthma: Mechanisms and treatment options
Adcock, I. M., Ford, P. A., Bhavsar, P. K., Ahmad, T., & Chung, K. F. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0028-4 · Cited by 99
Current concepts in glucocorticoid resistance
Yang, N., Ray, D. W., & Matthews, L. C. (2012) · Steroids · doi:10.1016/j.steroids.2012.05.007 · Cited by 104
Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
Hofbauer, L. C., & Rauner, M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0069 · Cited by 91
“However, this concept has been challenged by a recent study showing that, after binding of certain ligands such as the GR antagonist RU-486, GR is able to translocate into the nucleus independently of GR and modify the gene expression pattern of target cells (12).”
BackgroundFleseriu, M., Findling, J. W., Koch, C. A., Schlaffer, S.-M., Buchfelder, M., & Gross, C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1843 · Cited by 86
“Instead, it causes conformational changes in GR that modulate receptor dimerization, corepressor/activator interaction, DNA binding, and transcription (48–50) and modulates gene expression in distinct ways (51, 52).”
BackgroundKelly, A., Bowen, H., Jee, Y.-K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., & Lavender, P. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.010 · Cited by 83
Tieszen, C. R., Goyeneche, A. A., Brandhagen, B. N., Ortbahn, C. T., & Telleria, C. M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-207 · Cited by 80
“Although GR-b has been considered a dominant-negative regulator of GR-a [49-51], it was also reported that MF was the only compound of 57 potential natural and synthetic ligands to bind to the GR-b receptor isoform, and that interaction of GR-b with MF led to its nuclear translocation [52].”
BackgroundA gradient of glucocorticoid sensitivity among helper T cell cytokines
Banuelos, J., & Lu, N. Z. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.002 · Cited by 79
“GR-b binds to the GR antagonist RU-486, but not GR agonists, and has inhibitory effects on GR-a functions [25,26].”
BackgroundGlucocorticoid therapy and ocular hypertension
Dibas, A., & Yorio, T. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.018 · Cited by 75
“Lewis-Tuffin et al., 2007 reported that RU 486 bound GRβ weakly and slowly induced its nuclear translocation.”
BackgroundDominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 84
“The ability of GRb to modulate transcription, independent of GRa, might also contribute to the antagonistic effects of GRb on GRa actions [63].”
BackgroundGlucocorticoid Receptor β (GRβ): Beyond Its Dominant-Negative Function
Ramos‐Ramírez, P., & Tliba, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073649 · Cited by 84
Bosscher, K. D., Beck, I. M. E., & Haegeman, G. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.010 · Cited by 112
Transcriptional and Metabolic Effects of Glucocorticoid Receptor α and β Signaling in Zebrafish
Chatzopoulou, A., Roy, U., Meijer, A. H., Alia, A., Spaink, H. P., & Schaaf, M. J. M. (2015) · Endocrinology · doi:10.1210/en.2014-1941 · Cited by 68
Glucocorticoid receptor signaling in the eye
Sulaiman, R. S., Kadmiel, M., & Cidlowski, J. A. (2017) · Steroids · doi:10.1016/j.steroids.2017.11.002 · Cited by 75
Mechanisms of brain glucocorticoid resistance in stress-induced psychopathologies
Merkulov, V. M., Merkulova, T. I., & Bondar, N. P. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917030142 · Cited by 65
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 82
“Interestingly, apart from its dominant negative effect on the GRa isoform, GRb appears to have also independent functions and was shown to up or down-regulate several genes (for example S100P, ECM1, TNC, CA5A) in HeLa, COS-1 and U-2 cells, as investigated by microarray analysis [36,37].”
BackgroundHuman Glucocorticoid Receptor β Regulates Gluconeogenesis and Inflammation in Mouse Liver
He, B., Cruz-Topete, D., Oakley, R. H., Xiao, X., & Cidlowski, J. A. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00908-15 · Cited by 62
The neuroendocrine control of the innate immune system in health and brain diseases
Bellavance, M., & Rivest, S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01129.x · Cited by 60
Newton, R., & Giembycz, M. A. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13628 · Cited by 69
“For example, mifepristone (also known as RU486) appears to function as a full agonist in promoting the translocation of GR to the nucleus (Schaaf and Cidlowski, 2003; Chivers et al., 2004; Lewis-Tuffin et al., 2007).”
BackgroundStellato, C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.041 · Cited by 62
Brandhagen, B. N., Tieszen, C. R., Ulmer, T. M., Tracy, M. S., Goyeneche, A. A., & Telleria, C. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-35 · Cited by 60
Pietras, T., Panek, M., Tworek, D., Oszajca, K., Wujcik, R., Górski, P., Kuna, P., & Szemraj, J. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0512-5 · Cited by 56
“Numerous regulatory elements of DNA within the h-GR/NR3C1 gene promoter, coactivator proteins, cAMP activity, as well as complex protein kinase signal pathways play the crucial role here [3, 28–32].”
BackgroundContador, D., Ezquer, F. E., Maximiliano Espinosa, I., Arango-Rodríguez, M. L., Puebla, C., Sobrevía, L., & Conget, P. A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370214566565 · Cited by 54
Falchi, M., Varricchio, L., Martelli, F., Masiello, F., Federici, G., Zingariello, M., Girelli, G., Whitsett, C., Petricoin, E. F., Moestrup, S. K., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.114405 · Cited by 51
Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients
Goleva, E., Jackson, L. P., Gleason, M. C., & Leung, D. Y. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.001 · Cited by 50
Olivas-Aguirre, M., Torres-López, L., Pottosin, I. I., & Dobrovinskaya, O. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617937 · Cited by 58
“Alternative splicing of the 9β instead of the 9α exon results in the GRβ isoform, which is unable to bind GCs, but is transcriptionally active (36).”
BackgroundBoscaro, M., Giacchetti, G., & Ronconi, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06597.x · Cited by 55
The zebrafish as an in vivo model system for glucocorticoid resistance
Schoonheim, P. J., Chatzopoulou, A., & Schaaf, M. J. M. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.010 · Cited by 50
Nongenomic glucocorticoid effects and their mechanisms of action in vertebrates
Johnstone, W. M., Mankiewicz, J. L., Deck, C. A., & Borski, R. J. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.03.004 · Cited by 46
Air pollution and resistance to inhaled glucocorticoids: Evidence, mechanisms and gaps to fill
Rider, C. F., & Carlsten, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.005 · Cited by 41
Marwick, J. A., Adcock, I. M., & Chung, K. F. (2010) · Drugs · doi:10.2165/10898520-000000000-00000 · Cited by 47
“A role for GRb may also be found in light of recent evidence that it has an intrinsic transcriptional activity and may also be able to bind ligands.([41,43]) In light of these novel and important observations, the role of GRb in primary human cells and tissues, including those from disease, must be established.”
BackgroundInfluentialNaturally occurring C-terminal splice variants of nuclear receptors
van der Vaart, M., & Schaaf, M. J. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07007 · Cited by 40
“It has been shown that hGRβ is capable of binding the synthetic hGRα antagonist RU486 [Lewis-Tuffin et al., 2007].”
InfluentialZhang, L., Hapon, M. B., Goyeneche, A. A., Srinivasan, R., Gamarra-Luques, C. D., Callegari, E. A., Drappeau, D. D., Terpstra, E. J. M., Pan, B., Knapp, J. R., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.001 · Cited by 41
“…in all cancer cell lines we so far studied (Tieszen et al., 2011), and is able to bind mifepristone and transactivate genes in the absence of GRa (Kadmiel and Cidlowski, 2013; Lewis-Tuffin et al., 2007), plays a role in the anti-growth effect and ER stress response induced by the synthetic steroid.”
BackgroundThe clinical significance of the glucocorticoid receptors: Genetics and epigenetics
Motavalli, R., Majidi, T., Pourlak, T., Abediazar, S., Shoja, M. M., Vahed, S. Z., & Etemadi, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105952 · Cited by 41
Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension
Jeong, S., Patel, N. N., Edlund, C. K., Hartiala, J., Hazelett, D. J., Itakura, T., Wu, P., Avery, R. L., Davis, J. L., Flynn, H. W., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14803 · Cited by 39
Wang, Q., Lu, P., Shi, Z., Xu, Y., Xiang, J., Wang, Y., Deng, L., Xie, P., Yin, Y., Zhang, B., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8900-9 · Cited by 36
“co-factors such as ATF2 [5] and IGFR1 [6] can interact with TCF/LEF and activate its transcriptional activity in the absence of β-catenin stabilization.”
BackgroundDuBois, D. C., Sukumaran, S., Jusko, W. J., & Almon, R. R. (2013) · Steroids · doi:10.1016/j.steroids.2012.11.014 · Cited by 34
Kim, S.-H., Kim, D.-H., Lavender, P., Seo, J.-H., Kim, Y.-S., Park, J.-S., Kwak, S.-J., & Jee, Y.-K. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.5.033 · Cited by 34
“Recently it was confirmed that GRβ bind RU-486, glucocorticoid antagonist, as an ligand and GRβ bound with RU-486 can regulate gene expression, suggesting that GRβ may have some physiological roles other than as an just bystander or inhibitor of GRα (Lewis-Tuffin et al., 2007).”
BackgroundMifepristone Inhibits GRβ Coupled Prostate Cancer Cell Proliferation
Ligr, M., Li, Y., Logan, S. K., Taneja, S. S., Melamed, J., Lepor, H., Garabedian, M. J., & Lee, P. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.102 · Cited by 34
Keenan, C. R., Radojicic, D., Li, M., Radwan, A. M., & Stewart, A. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.006 · Cited by 39
Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression
Ponikwicka‐Tyszko, D., Chruściel, M., Stelmaszewska, J., Bernaczyk, P., Chrusciel, P., Sztachelska, M., Scheinin, M., Bidziński, M., Szamatowicz, J., Huhtaniemi, I. T., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.035 · Cited by 34
Generalized and tissue specific glucocorticoid resistance
Martins, C. S., & de Castro, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111277 · Cited by 31
Glucocorticoid receptor activities in the zebrafish model: a review
Dinarello, A., Licciardello, G., Fontana, C. M., Tiso, N., Argenton, F., & Valle, L. D. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0173 · Cited by 39
Bury, N. R. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.06.030 · Cited by 33
“It does, however, form 85 heterodimers with GRα to act as a dominant-negative inhibitor of GRα gene expression 86 (Bamberger et al 1995), and has also been shown to directly stimulate or repress a number 87 of genes not regulated by GRα (Kino et al 2009, Lewis-Tuffin et al 2007).”
BackgroundDas, S., Schapira, M., Tomic‐Canic, M., Goyanka, R., Cardozo, T. J., & Samuels, H. H. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0080 · Cited by 30
Rider, C. F., Altonsy, M. O., Mostafa, M., Shah, S., Sasse, S. K., Manson, M. L., Yan, D., Mårdh, C. K., Miller‐Larsson, A., Gerber, A. N., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112755 · Cited by 29
“Mifepristone (RU486), which promotes nuclear translocation of GR (Chivers et al., 2004; Lewis-Tuffin et al., 2007), was essentially inactive (EMax 1.6 6 0.3-fold) on the 2 GRE reporter in BEAS-2B cells (Supplemental Fig.”
BackgroundInfluentialMolecular Biology of Glucocorticoid Signaling
Arango-Lievano, M., Lambert, W. M., & Jeanneteau, F. D. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_2 · Cited by 29
“GRβ resides permanently in the nucleus and acts as a dominant negative inhibitor of the GRα isoform, but can also directly regulate genes that are not regulated by the α isoform [ 43 , 44 ].”
BackgroundGlucocorticoid Receptor in Human Respiratory Epithelial Cells
Pujols, L., Mullol, J., & Picado, C. (2009) · NeuroImmunoModulation · doi:10.1159/000216187 · Cited by 31
“However, it has been recently found that GRβ can bind the GC antagonist RU-486 [”
BackgroundHägg, P. M., Hurskainen, T., Palatsi, R., Ilves, M., & Oikarinen, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09518.x · Cited by 31
Familial Glucocorticoid Resistance Caused by a Novel Frameshift Glucocorticoid Receptor Mutation
Trebble, P., Matthews, L. C., Blaikley, J., Wayte, A. W. O., Black, G. C. M., Wilton, A., & Ray, D. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0705 · Cited by 29
“The dominant negative effects of Δ612GR on wild-type GR transactivation were interesting because previous reports have suggested that the GRβ splice isoform of GR, similarly incapable of binding glucocorticoid agonists, can exert dominant negative effects on GR transactivation (26-32), although this is controversial (…”
BackgroundGlucocorticoid receptor: implications for rheumatic diseases.
Kino, T., Charmandari, E., & Chrousos, G. P. (2011) · Clinical and Experimental Rheumatology · Cited by 32
Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses
Kubin, M. E., Hägg, P. M., Kokkonen, N., Väyrynen, J. P., Haapasaari, K., Moilanen, J. M., Kallioinen, M. J., Hurskainen, T. L., & Tasanen, K. (2016) · European Journal of Dermatology · doi:10.1684/ejd.2015.2691 · Cited by 28
Antiprogestins in gynecological diseases
Goyeneche, A. A., & Telleria, C. M. (2014) · Reproduction · doi:10.1530/rep-14-0416 · Cited by 25
“…has been considered a dominant negative regulator of GRa (Oakley et al. 1999, Yudt et al. 2003, Taniguchi et al. 2010), it was also reported to function, in the absence of GRa, as a receptor for mifepristone, leading to nuclear translocation and transcriptional activity (Lewis-Tuffin et al. 2007).”
BackgroundThe role of glucocorticoid receptor in prostate cancer progression: from bench to bedside
Hu, J., & Chen, Q. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1476-8 · Cited by 28
Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Flynn, J. K., Dankers, W., & Morand, E. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01684 · Cited by 26
Gamarra-Luques, C. D., Hapon, M. B., Goyeneche, A. A., & Telleria, C. M. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-45 · Cited by 26
“It remains to be determined, however, whether GRβ, which was reported capable of binding mifepristone [43], plays a role in the anti-growth effect of antiprogestins, as this receptor isoform seems to be present in all cell lines we studied so far [40].”
BackgroundKeenan, C. R., Lew, M. J., & Stewart, A. G. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.008 · Cited by 24
Marchi, D., & van Eeden, F. J. M. (2021) · Cells · doi:10.3390/cells10123441 · Cited by 26
The Human Glucocorticoid Receptor Beta: From Molecular Mechanisms to Clinical Implications
Nicolaides, N. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac150 · Cited by 23
Chatzopoulou, A., Schoonheim, P. J., Torraca, V., Meijer, A. H., Spaink, H. P., & Schaaf, M. J. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.036 · Cited by 22
“Additionally, transcriptome analyses of cultured cells showed that hGRb can direct gene transcription independently of hGRa activation (Kino et al., 2009a,b; Lewis-Tuffin et al., 2007).”
Background
Metadata
- Authors
- Lewis-Tuffin, L. J., Jewell, C. M., Bienstock, R. J., Collins, J. B., & Cidlowski, J. A.
- Affiliations
- Laboratory of Signal Transduction
- Scientific Computing Laboratory
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-03-01
- Volume
- 27
- Issue
- 6
- Pages
- 2266-2282
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1820503
- OpenAlex
- W2143578597
- Cited by
- 175
- References
- 40
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 2 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 14 · 2015: 14 · 2014: 12 · 2013: 10 · 2012: 12
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- University of South Carolina
- National Institutes of Health
- School of Medicine, University of South Carolina
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Environmental Health Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- glucocorticoid receptor beta, RU486, mifepristone, orphan receptors, nuclear translocation, ligand binding, glucocorticoid receptor antagonist, transcriptional regulation, receptor isoforms, helix 12, ligand-binding domain, gene expression regulation
- MeSH terms
- Animals, Cell Line, Cell Nucleus, Chlorocebus aethiops, Gene Expression Regulation, Humans, Ligands, Models, Molecular, Receptors, Glucocorticoid, Transcription, Genetic, Mifepristone, Protein Structure, Tertiary, Computational Biology, Protein Isoforms, Gene Expression Profiling, Protein Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.